Physician profile

Rafael Harari

Cardiovascular Disease · New York, NY

NPI 1225304868

$6,608.94

in general payments reported to CMS, 2019-2025

17 companies · $2,388 in 2025

The $2,388 reported for 2025 was more than what 86% of Cardiovascular Disease providers received nationally (typical 2025 total: $433).

Payments by year

General payments by program year, as reported to CMS.

What the payments were for

Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.

View as a table
Payment typeAmount (2023-2025)
Food and Beverage$2,602.06
Travel and Lodging$981.77

Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.

Who reported paying

General payments only, as reported to CMS. Product names cover 2023-2025.

CompanyGeneral paymentsYearsTop products
Abbott Laboratories $4,038.77 2019-2025 Triclip, Amplatzer, Mitraclip
Medtronic, INC. $484.22 2023-2025 Corevalve Evolut R
Stryker Corporation $319.54 2025 Flowtriever Catheter, S, Ct Thrombectomy System Kit, Flowtriever
Inari Medical, INC. $283.40 2023-2024 Ct Thrombectomy System Kit, Flowtriever Catheter, S
Boston Scientific Corporation $258.74 2020-2022
Edwards Lifesciences Corporation $257.85 2023-2025 Sapien 3 Ultra Resilia
Abiomed $204.16 2019-2025
Shockwave Medical, INC $168.39 2022
Siemens Medical Solutions USA, INC. $148.90 2021
Bard Peripheral Vascular, INC. $112.68 2023 True Dilatation
Irhythm Technologies, INC. $83.34 2020
W. L. Gore & Associates, INC. $80.33 2024-2025 Gore Cardioform Septal Occluder
Terumo Medical Corporation $76.79 2019-2021
Angiodynamics, INC. $24.45 2021
Amgen INC. $23.87 2019
Show all 17 companies
CompanyGeneral paymentsYearsTop products
Chiesi USA, INC. $22.67 2020
Lantheus Medical Imaging, INC. $20.84 2019

Drugs and devices associated with these payments

CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.

If you want to bring it up

Most clinicians are glad to talk about this. A respectful way in:

These are normal questions. A good clinician will welcome them.

Share this page

Payment summary

Rafael Harari

$6,608.94

in general payments reported 2019-2025

Years
2019-2025
Top company
Abbott Laboratories
Context
The $2,388 reported for 2025 was more than what 86% of Cardiovascular Disease providers received nationally (typical 2025 total: $433).

https://glasscript.com/doctor/1341965/rafael-harari

Source: CMS Open Payments, program years 2019-2025. Payments are legal and often routine.

Keep an eye on this page

Get an email when the next June refresh changes this page. No account needed.

Watch this doctor

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.